Oral Lesions Associated with 2019-nCoV
-
摘要: 新型冠状病毒是2019年底开始流行全球的传染病(COVID-19)-新型冠状病毒病的病原体,对人体呼吸道为主的多个器官造成损伤,口腔损害被认为也是该病常见表现。分析2019年12月至2021年11月期间发表的有关新冠病毒感染与口腔表现文献,总结COVID-19相关口腔损害特征及其可能机制。发现所报告的病例中口腔病变以味觉功能障碍、口干症和溃疡性损害等多见。口腔病损发病机制尚未完全清楚,但口腔上皮细胞广发存在2019-nCoV进入细胞受体ACE2,病毒复制并可能造成组织炎症和破坏是基本的致病机制。Abstract: COVID-19 virus is the pathogen of the new type of corona virus disease 2019, a global infectious disease that began to spread at the end of 2019. It has caused damage to multiple organs particularly human respiratory tract. Oral lesions is considered to be a common manifestation of this disease. This article summarized the characteristics and possible mechanisms of COVID-19 related oral damage in novel coronavirus infections and oral manifestations from publications between December 2019 and November 2021. It showed that the oral manifestations of the reported cases were mainly gustatory dysfunction, xerostomia and ulcerative lesions. The mechanism of oral lesions is not yet fully understood, but 2019-nCoV enters the cell receptor ACE2 widely in oral epithelial cells. Virus replication and possible tissue inflammation and destruction could be its possible pathogenic mechanisms.
-
Key words:
- Coronavirus 2019 /
- COVID-19 /
- Oral mucosal lesions /
- Periodontal disease
-
[1] 王业明,徐逸天,曹彬. 新型冠状病毒感染传播、发病机制、诊断和治疗的进展[J]. 中华结核和呼吸杂志,2021,44(7):684-688. doi: 10.3760/cma.j.cn112147-20201120-01106 [2] Lu R,Zhao X,Li J,et al. Genomic characterisation and epidemiology of 2019 novel coronavirus:Implications for virus origins and receptor binding[J]. Lancet Lond Engl,2020,3959(3):565-574. [3] Chen L,Zhao J,Peng J,et al. Detection of SARS-CoV-2 in saliva and characterization of oral symptoms in COVID-19 patients[J]. Cell Prolif,2020,53(12):12923. [4] Hindson J. COVID-19:Faecal–oral transmission?[J]. Nature Reviews Gastroenterology &Hepatology,2020,17(5):259. [5] To K K,Tsang O T,YipC C,et al. Consistent detection of 2019 novel coronavirus in saliva[J]. Clin Infect Dis,2020,71(5):841-843. [6] Xu H,Zhong L,Deng J,et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa[J]. Int J Oral Sci,2020,12(1):8. doi: 10.1038/s41368-020-0074-x [7] Tay M Z,Poh C M,Rea L,et al. The trinity of COVID‐19:immunity,inflammation and intervention[J]. Nat Rev Immunol,2020,20(6):363-374. [8] Sapkota D,Søland T M,Galtung H K,et al. COVID-19 salivary signature:Diagnostic and research opportunities[J]. J Clin Pathol,2020,74(6):344-349. [9] Santos J A,Normando A G C,Carvalho da Silva R L,et al. Oral mucosal lesions ina COVID‐19 patient:New signs or secondary manifestations?[J]. Int J Infect Dis,2020,97(2):326-328. [10] Mullol J,Alobid I,Marino-Sanchez F,et al. The loss of smell and taste in the COVID-19 outbreak:A tale of many countries[J]. Curr Allergy Asthma Rep,2020,20(10):61. doi: 10.1007/s11882-020-00961-1 [11] Benazzo M,Cassaniti I,Maiorano E,et al. SARS‐CoV‐2 virologic and immunologic correlates in patients with olfactory and taste disorders[J]. Microorganisms,2020,8(7):1052. doi: 10.3390/microorganisms8071052 [12] MarinoSanchez F,SantamariaGadea A,De Los Santos G,et al. Psychophysical olfactory testing in COVID-19:Is smell function really impaired in nearly all patients?[J]. Int Forum Allergy Rhinol,2020,10(8):951-952. [13] Sakaguchi W,Kubota N,Shimizu T,et al. Existence of SARS-CoV-2 entry molecules in the oral cavity[J]. Int J Mol Sci,2020,21(17):6000. doi: 10.3390/ijms21176000 [14] Finsterer J,Stollberger C. Causes of hypogeusia/hyposmia in SARS-CoV2 infected patients[J]. J Med Virol,2020,92(12):1793-1794. [15] Jothimani D,Kailasam E,Danielraj S,et al. COVID-19:Poor outcomes in patients with zinc deficiency[J]. Int J Infect Dis,2020,100(3):343-349. [16] Favia G,Tempesta A,Barile G,et al. Covid-19 symptomatic patients with oral lesions:Clinical and histopathological study on 123 cases of the university hospital policlinic of bari with a purpose of a new classification[J]. J Clin Med,2021,10(4):757. doi: 10.3390/jcm10040757 [17] Gherlone E F,Polizzi E,Tete G,et al. Frequent and persistent salivary gland ectasia and oral disease after COVID-19[J]. J Dent Res,2021,100(5):464-471. doi: 10.1177/0022034521997112 [18] Farshidfar N, Hamedani S. Hyposalivation as a potential risk for SARS-CoV-2 infection: Inhibitory role of saliva[J]. Oral Dis, 2020, 27(Suppl 3): 750-751. [19] Biadsee A,Kassem F,Dagan O,et al. Olfactory and oral manifestations of COVID-19:Sex-related symptoms-A potential pathway to early diagnosis[J]. Otolaryngol Head Neck Surg,2020,163(4):722-728. doi: 10.1177/0194599820934380 [20] Hockova B,Riad A,Valky J,et al. Oral Complications of ICU patients with COVID-19:Case-series and review of two hundred tencases[J]. J Clin Med,2021,10(4):581. doi: 10.3390/jcm10040581 [21] Iranmanesh B,Khalili M,Amiri R,et al. Oral manifestations of COVID-19 disease:A review article[J]. Dermatol Ther,2021,34(1):14578. [22] Riad A,Gomaa E,Hockova B,et al. Oral candidiasis of COVID-19 patients:Case report and review of evidence[J]. J CosmetDermatol,2021,20(6):1580-1584. [23] Le Balch P,Pinceaux K,Pronier C,et al. Herpes simplex virus and cytomegalovirus reactivations among severe COVID-19 patients[J]. Crit Care,2020,24(1):530. doi: 10.1186/s13054-020-03252-3 [24] Burgos Ponce J, Trijoe K C. Overlapping findings or oral manifestations in new SARS- CoV-2 infection[J]. Oral Dis, 2020 , 27 (Suppl 3): 781-782. [25] Patel J, Woolley J. Necrotizing periodontal disease: Oral manifestation of COVID‐19[J]. Oral Dis, 2021, 27 (Suppl 3): 768-769. [26] Anand P S,Jadhav P,Kamath K P,et al. A case-control study on the association between periodontitis and coronavirus disease (COVID-19)[J]. J Periodontol,2021,18(1):1-7. [27] Halepas S,Lee K C,Myers A,et al. Oral manifestations of COVID-2019-related multisystem inflammatory syndrome in children:A review of 47 pediatric patients[J]. J Am Dent Assoc,2021,152(3):202-208. doi: 10.1016/j.adaj.2020.11.014
点击查看大图
计量
- 文章访问数: 3942
- HTML全文浏览量: 2140
- PDF下载量: 29
- 被引次数: 0